Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)

China flag China · Delayed Price · Currency is CNY
12.17
+0.16 (1.33%)
Mar 10, 2026, 3:00 PM CST
30.02%
Market Cap 5.34B
Revenue (ttm) 1.68B
Net Income (ttm) 295.36M
Shares Out 439.08M
EPS (ttm) 0.67
PE Ratio 18.16
Forward PE 17.51
Dividend 0.25 (2.08%)
Ex-Dividend Date Jan 16, 2026
Volume 4,540,700
Average Volume 8,579,188
Open 12.10
Previous Close 12.01
Day's Range 12.03 - 12.23
52-Week Range 8.47 - 13.50
Beta 0.35
RSI 51.62
Earnings Date Apr 25, 2026

About SHA:603998

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, gynecological drugs, and anti-infective drugs. The company's main products include Xuesetong dispersible tablets, Xuesetong tablets, Garcinia bone-strengthening tablets, Dieda Huoxue ca... [Read more]

Sector Healthcare
Founded 2002
Employees 1,807
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603998
Full Company Profile

Financial Performance

In 2024, SHA:603998's revenue was 1.78 billion, an increase of 9.15% compared to the previous year's 1.63 billion. Earnings were 255.22 million, an increase of 36.61%.

Financial Statements

News

There is no news available yet.